March 5, 2014
/PRNewswire/ -- IGI Laboratories, Inc. (NYSE Amex: IG), a
based topical generic pharmaceutical company, will be presenting at the 26th Annual ROTH Conference. The Conference will take place on
March 9-12, 2014
at the Ritz-Carlton in
Dana Point, California
, CEO and President and
, Chief Financial Officer of IGI Laboratories, Inc. will present on
Monday March 10
, 2014 at 12:00 p.m. PT / 3:00 p.m. ET. Investors attending the conferences who wish to meet with Mr. Grenfell-Gardner and Mrs. Collins for a one-on-one meeting should contact their ROTH Capital representative directly.
The presentation will be webcast and will be accessible online on the investors section of the Company's website at
. A replay will be available for 90 days.
About IGI Laboratories, Inc.
IGI Laboratories is a generic topical pharmaceutical company. We develop and manufacture topical formulations for the pharmaceutical, OTC, and cosmetic markets. Our mission is to be a leading player in the generic topical prescription drug market.
SOURCE IGI Laboratories, Inc.